Mayo Clinic: Hyperoxaluria trials

The registry lists 13 Hyperoxaluria studies with Mayo Clinic as lead sponsor. 4 are open to participants now and 4 have results posted.

Phase 1 4Phase 2 4Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Monogenic Kidney Stone - Genetic TestingRecruitingNCT03305835
• Prospective Research Rare Kidney Stones (ProRKS)RecruitingNCT02780297
• Rare Kidney Stone Consortium BiobankRecruitingNCT02026388
• Rare Kidney Stone Consortium Patient RegistryRecruitingNCT00588562
• Hydroxyproline Influence on Oxalate MetabolismCompletedNCT02038543Phase 1/2Results posted
• Oxazyme in Patients With HyperoxaluriaCompletedNCT01127087Phase 1/2Results posted
• Use of Oral Probiotics to Reduce Urinary Oxalate ExcretionCompletedNCT00587041Phase 1/2Results posted
• Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary HyperoxaluriaCompletedNCT00283387Phase 2Results posted
• Primary Hyperoxaluria Mutation Genotyping/PhenotypingCompletedNCT02340689
• International Registry for Primary HyperoxaluriaWithdrawnNCT00875823
• Primary Hyperoxaluria Mutation GenotypingCompletedNCT00589225
• Enteric Oxalate Absorption Study in Unclassified HyperoxaluriaCompletedNCT00588120Phase 1
• Renal Protective Effect of ACEI and ARB in Primary HyperoxaluriaWithdrawnNCT00280215Phase 3